Hyoscine Butylbromide Injection Supplier, Manufacturer & Global Exporter

Hyoscine Butylbromide Injection Supplier, as a trusted we provide high-quality, sterile injections to hospitals, clinics, and healthcare providers both in India and globally. Our products are manufactured under WHO-GMP and ISO standards to ensure maximum safety, efficacy, and patient satisfaction. Hyoscine Butylbromide Injection is a widely used antispasmodic medication indicated for the relief of smooth muscle spasms in the gastrointestinal and genitourinary tract.

About Hyoscine Butylbromide Injection

Hyoscine Butylbromide, also known as scopolamine butylbromide, works by inhibiting the action of acetylcholine on smooth muscles, thereby relieving cramps and spasms. Being a certified Hyoscine Butylbromide Injection Supplier in India, we ensure that each batch undergoes rigorous quality control for sterility, potency, and stability. Our global distribution network ensures reliable supply to healthcare providers worldwide, making us a leading Hyoscine Butylbromide Injection exporter and supplier.

Key Benefits and Uses

• Provides rapid relief from abdominal pain caused by gastrointestinal spasms.

• Alleviates bladder and ureteral smooth muscle spasms.

• Used in colicky pain, irritable bowel syndrome, and renal colic management.

• Supports diagnostic procedures by reducing involuntary smooth muscle contractions.

• Improves patient comfort during abdominal or pelvic interventions.

As a trusted Hyoscine Butylbromide Injection Supplier, we focus on delivering sterile, high-quality injections suitable for hospital use, clinical settings, and emergency care. Our role as a Hyoscine Butylbromide Injection global supplier ensures uninterrupted access to this essential antispasmodic therapy.

Dosage and Administration

Hyoscine Butylbromide Injection is administered via intramuscular (IM), intravenous (IV), or subcutaneous (SC) routes, as prescribed by a qualified healthcare professional. The dosage depends on the patient’s age, medical condition, and clinical response. As a responsible Hyoscine Butylbromide Injection Supplier, we provide various vial sizes and concentrations suitable for hospital and clinical use.

Precautions

As a leading Hyoscine Butylbromide Injection Supplier, we recommend the following precautions:

• Administer only under the supervision of a qualified healthcare professional.

• Avoid use in patients with glaucoma, myasthenia gravis, or severe heart conditions.

• Monitor blood pressure and heart rate during intravenous administration.

• Pregnant or breastfeeding women should consult a physician before use.

• Keep out of reach of children and store in a cool, dry place.

These precautions highlight our commitment as a Hyoscine Butylbromide Injection Supplier to safe and effective patient care.

Possible Side Effects

While generally well tolerated, some patients may experience:

• Dry mouth or throat

• Blurred vision or difficulty focusing

• Mild dizziness or drowsiness

• Rare allergic reactions including rash, itching, or swelling

• Tachycardia or palpitations in sensitive individuals

As a transparent Hyoscine Butylbromide Injection Supplier, we ensure healthcare providers and patients are well-informed about proper usage and potential side effects to maximize safety and effectiveness.

Why Choose Us?

• WHO-GMP & ISO-certified Hyoscine Butylbromide Injection Supplier in India

• Recognized global supplier and exporter with reliable international distribution

• Flexible third-party and contract manufacturing services

• Stringent quality assurance and testing at every stage of production

Our position as a leading Hyoscine Butylbromide Injection Supplier reflects our dedication to providing safe, high-quality, and effective antispasmodic therapy for global healthcare needs.

Global Distribution Network

With a strong logistics and compliance framework, we successfully export Hyoscine Butylbromide Injection Supplier to a broad range of international markets, including: Venezuela, Brazil, Cambodia, Philippines, Nigeria, Myanmar, Thailand, Singapore, Russia, Kyrgyzstan, Tajikistan, Kenya, Zimbabwe, Somalia, Djibouti, Belarus, Macedonian, And Turkey.